<dl id="6s86i"><acronym id="6s86i"></acronym></dl>
<button id="6s86i"><input id="6s86i"></input></button>
  • <button id="6s86i"><input id="6s86i"></input></button>
    • 18717796589
    18717796589

    證據(jù)文獻

    NO 論文 登載期刊 PM ID 全文鏈接 中文鏈接
    1 輔助免疫細胞療法與全身系統(tǒng)性療法結合治療實體瘤的療效 Anticancer Research 42: 4179-4187 / 2022 35896218 https://ar.iiarjournals.org/content/42/8/4179 http://www.sunny-funny.com/laitian/results/22.html
    2 食管癌對免疫細胞療法和低劑量納武單抗聯(lián)合治療有反應 Journal of Medical Case Reports 15, Article number: 191 / 2021 33827668 https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z http://www.sunny-funny.com/laitian/results/23.html
    3 免疫細胞療法治療晚期/復發(fā)性乳腺癌的預后因素 Anticancer Research 41:4133-4141 / 2021 34281884 https://ar.iiarjournals.org/content/41/8/4133.long http://www.sunny-funny.com/laitian/results/1.html
    4 過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響 CYTOTHERAPYFeb;23(2):137-145/2020 32907781 https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6 http://www.sunny-funny.com/laitian/results/2.html
    5 接受一線化療免疫治療的轉移性結直腸癌患者的免疫狀態(tài)變化 Anticancer Research 40:4763-4771 / 2020 32727803 https://ar.iiarjournals.org/content/40/8/4763.long http://www.sunny-funny.com/laitian/results/3.html
    6 過繼免疫細胞治療子宮頸神經(jīng)內(nèi)分泌癌 Anticancer Research 40:4741-4748 / 2020 32727800 https://ar.iiarjournals.org/content/40/8/4763 http://www.sunny-funny.com/laitian/results/4.html
    7 免疫細胞治療子宮內(nèi)膜癌和宮頸癌預后因素的回顧性研究 Anticancer Research 40:4729-4740 / 2020 32727799 https://ar.iiarjournals.org/content/40/8/4729.long http://www.sunny-funny.com/laitian/results/5.html
    8 適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響 Cancer Med 9(14):4907-4917 / 2020 32529780 https://ar.iiarjournals.org/content/40/8/4729.long http://www.sunny-funny.com/laitian/results/6.html
    9 γδT細胞免疫治療實體瘤預后因素的研究 CYTOTHERAPY Jun;22(6):329-336 / 2020 32303429 https://pubmed.ncbi.nlm.nih.gov/32303429/ http://www.sunny-funny.com/laitian/results/7.html
    10 免疫細胞聯(lián)合一線化療治療結直腸癌的預后因素:一項回顧性研究 Anticancer Research 39: 4525-4532 / 2019 31366555 https://pubmed.ncbi.nlm.nih.gov/31366555/ http://www.sunny-funny.com/laitian/results/8.html
    11 免疫細胞治療胰腺癌患者的預后因素 Anticancer Research 38 (7) 4353-4360 / 2018 29970573 https://pubmed.ncbi.nlm.nih.gov/29970573/ http://www.sunny-funny.com/laitian/results/9.html
    12 腫瘤內(nèi)注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯(lián)合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究 Oncotarget Dec5;9(2):2838-2847./2017 29416816 https://pubmed.ncbi.nlm.nih.gov/29416816/ http://www.sunny-funny.com/laitian/results/10.html
    13 全身靜脈過繼轉移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質瘤患者淋巴細胞減少 Anticancer Research Jul;37(7):3921-3932./2017 28668896 https://pubmed.ncbi.nlm.nih.gov/28668896/ http://www.sunny-funny.com/laitian/results/11.html
    14 過繼免疫聯(lián)合化療治療IV期結直腸癌的臨床研究(COMVI研究) Anticancer Research Jul;37(7):3941-3946. / 2017 28668898 https://pubmed.ncbi.nlm.nih.gov/28668898/ http://www.sunny-funny.com/laitian/results/12.html
    15 過繼免疫細胞療法治療晚期胃癌的回顧性研究 Anticancer Research Jul;37(7):3947-3954. / 2017 28668899 https://pubmed.ncbi.nlm.nih.gov/28668899/ http://www.sunny-funny.com/laitian/results/13.html
    16 mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質量和性能 Mol Ther Oncolytics.Nov 16;3:16024. / 2016 27909701 https://pubmed.ncbi.nlm.nih.gov/27909701/ http://www.sunny-funny.com/laitian/results/14.html
    17 活化αβT細胞過繼免疫化療治療IV期結直腸癌 Anticancer Research Jul;36(7):3741-6. / 2016 27354648 https://pubmed.ncbi.nlm.nih.gov/27354648/ http://www.sunny-funny.com/laitian/results/15.html
    18 WT1抗原在多種實體癌細胞中表達的免疫組織化學分析 Anticancer Research 36(7):3715-3724 / 2016 27354645 https://pubmed.ncbi.nlm.nih.gov/27354645/ http://www.sunny-funny.com/laitian/results/16.html
    19 自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損 Anticancer Research 36(7):3715-3724 / 2016 26168498 https://pubmed.ncbi.nlm.nih.gov/26168498/ http://www.sunny-funny.com/laitian/results/17.html
    20 免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價 Anticancer Research 35(8):4535-4543 / 2015 25075106 https://pubmed.ncbi.nlm.nih.gov/25075106/ http://www.sunny-funny.com/laitian/results/18.html
    21 在晚期癌癥患者中評估細胞免疫狀態(tài)受損和失衡,并通過過繼性T細胞免疫治療恢復T細胞免疫狀態(tài) International Immunopharmacology18(1):90-97. / 2014 24269583 https://pubmed.ncbi.nlm.nih.gov/24269583/ http://www.sunny-funny.com/laitian/results/19.html
    22 封閉流式電穿孔系統(tǒng)治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療 Anticancer Research 33(7):2971-6. / 2013 23780988 https://pubmed.ncbi.nlm.nih.gov/23780988/ http://www.sunny-funny.com/laitian/results/20.html
    23 晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長:一項多中心歷史性隊列研究的結果 Cancer Immunology, Immunotherapy 61:1781-1790. / 2012 22422103 https://pubmed.ncbi.nlm.nih.gov/22422103/ http://www.sunny-funny.com/laitian/results/21.html

    国产亚洲综合久久| 99精品久久久中文字幕| 无码狠狠躁久久久久久久| 久久91精品久久91综合| 强姧伦久久久久久久久| 久久久一区二区三区| 国产无套内射久久久国产| 精品久久久久久无码人妻中文字幕 | 久久久久亚洲精品无码蜜桃| 久久精品无码一区二区app| 国产香蕉久久精品综合网| 久久精品噜噜噜成人av| 久久国产视频99电影| 模特私拍国产精品久久| 久久久久亚洲av无码尤物| 久久精品国产一区二区三区不卡 | 91久久精品国产91久久性色tv| 亚洲综合日韩久久成人AV| 国产成人久久精品| 精品乱码久久久久久久| 久久se精品一区二区国产| 国产午夜久久影院| 国产精品久久久久久久午夜片| 天天拍夜夜添久久精品| 91精品国产免费久久国语蜜臀 | 2021国内久久精品| 久久99精品视香蕉蕉| 亚洲人成精品久久久久| 香蕉aa三级久久毛片| 久久香蕉国产线看观看猫咪AV| 蜜臀av性久久久久蜜臀aⅴ麻豆| 亚洲αv久久久噜噜噜噜噜| 久久天天躁狠狠躁夜夜2020 | 久久人人爽爽人人爽人人片AV | 国产精品久久久久久一区二区三区| 99精品久久99久久久久| 久久久久人妻精品一区蜜桃| 久久这里只有精品66| 一本久道久久综合狠狠爱| 国内精品久久久久久不卡影院| 国产成人精品综合久久久|